{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:04:30Z","timestamp":1774494270826,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mu heavy chain disease is a rare lymphoid neoplasm characterized by vacuolated bone marrow plasma cells and secretion of defective mu immunoglobulin heavy chains. The biological basis of mu heavy chain disease is poorly understood.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report a case of mu heavy chain disease with <jats:italic>MYD88<\/jats:italic> L265P mutation and deletion of 6q, genetic aberrations that are both strongly associated with lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia. Identification of the truncated mu immunoglobulin was facilitated by mass spectrometric analysis of the patient\u2019s serum.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Mu heavy chain disease has been described as similar to chronic lymphocytic leukemia; however, the frequency of lymphocytosis in mu heavy chain disease has not been previously reported. We reviewed all previously published mu heavy chain disease reports and found that lymphocytosis is uncommon in the entity. This finding, along with the emerging genetic feature of recurrent <jats:italic>MYD88<\/jats:italic> mutation in mu heavy chain disease, argues that at least a significant subset of cases are more similar to lymphoplasmacytic lymphoma than to chronic lymphocytic leukemia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-022-01244-1","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T07:03:39Z","timestamp":1659683019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Vandana","family":"Baloda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mindy C.","family":"Kohlhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana A.","family":"Yatsenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mounzer E.","family":"Agha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav","family":"Djokic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven H.","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathanael G.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"key":"1244_CR1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised","author":"SHCE Swerdlow","year":"2017","unstructured":"Swerdlow SHCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised. 4th ed. Lyon: IARC; 2017.","edition":"4"},{"issue":"2","key":"1244_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41408-021-00408-4","volume":"11","author":"DL Murray","year":"2021","unstructured":"Murray DL, Puig N, Kristinsson S, Usmani SZ, Dispenzieri A, Bianchi G, et al. Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report. Blood Cancer J. 2021;11(2):24.","journal-title":"Blood Cancer J"},{"issue":"11","key":"1244_CR3","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1021\/pr5005967","volume":"13","author":"DR Barnidge","year":"2014","unstructured":"Barnidge DR, Dasari S, Ramirez-Alvarado M, Fontan A, Willrich MAV, Tschumper RC, et al. Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry. J Proteome Res. 2014;13(11):5198\u2013205.","journal-title":"J Proteome Res"},{"issue":"4","key":"1244_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1309\/6U88-357U-UKJ5-YPT3","volume":"116","author":"A Mansoor","year":"2001","unstructured":"Mansoor A, Medeiros LJ, Weber DM, Alexanian R, Hayes K, Jones D, et al. Cytogenetic Findings in Lymphoplasmacytic Lymphoma \/Waldenstr\u00f6m Macroglobulinemia: Chromosomal Abnormalities Are Associated With the Polymorphous Subtype and an Aggressive Clinical Course. Am J Clin Pathol. 2001;116(4):543\u20139.","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"1244_CR5","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJMoa1200710","volume":"367","author":"SP Treon","year":"2012","unstructured":"Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. MYD88 L265P Somatic Mutation in Waldenstr\u00f6m\u2019s Macroglobulinemia. N Engl J Med. 2012;367(9):826\u201333.","journal-title":"N Engl J Med"},{"issue":"7","key":"1244_CR6","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.3324\/haematol.2020.277137","volume":"106","author":"H Vergneault","year":"2021","unstructured":"Vergneault H, Bengoufa D, Frazier-Mironer A, Brocheriou I, Bitoun S, Villesuzanne C, et al. Light chain proteinuria revealing mu-heavy chain disease: an atypical presentation of Waldenstr\u00f6m macroglobulinemia in two cases. Haematologica. 2021;106(7):2034\u20136.","journal-title":"Haematologica"},{"issue":"19","key":"1244_CR7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1056\/NEJM197005072821902","volume":"282","author":"HS Ballard","year":"1970","unstructured":"Ballard HS, Hamilton LM, Marcus AJ, Illes CH. A new variant of heavy-chain disease (mu-chain disease). N Engl J Med. 1970;282(19):1060\u20132.","journal-title":"N Engl J Med"},{"issue":"2","key":"1244_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1182\/blood.V36.2.137.137","volume":"36","author":"FA Forte","year":"1970","unstructured":"Forte FA, Prelli F, Yount WJ, Jerry LM, Kochwa S, Franklin EC, et al. Heavy chain disease of the gamma (gamma M) type: report of the first case. Blood. 1970;36(2):137\u201344.","journal-title":"Blood"},{"issue":"1","key":"1244_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/ajh.2830400112","volume":"40","author":"DL Wahner-Roedler","year":"1992","unstructured":"Wahner-Roedler DL, Kyle RA. \u03bc-heavy chain disease: Presentation as a benign monoclonal gammopathy. Am J Hematol. 1992;40(1):56\u201360.","journal-title":"Am J Hematol"},{"issue":"8","key":"1244_CR10","first-page":"10","volume":"48","author":"NE Andreeva","year":"1976","unstructured":"Andreeva NE, Antipova LG, Chernokhvostova EV, Batalova TN. Disease of heavy chains mu (new forms of paraproteinemic hemoblastoses). Ter Arkh. 1976;48(8):10\u20135.","journal-title":"Ter Arkh"},{"issue":"7","key":"1244_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/0161-5890(86)90083-0","volume":"23","author":"A Bakhshi","year":"1986","unstructured":"Bakhshi A, Guglielmi P, Coligan JE, Gamza F, Waldmann TA, Korsmeyer SJ. A pre-translational defect in a case of human mu heavy chain disease. Mol Immunol. 1986;23(7):725\u201332.","journal-title":"Mol Immunol"},{"issue":"4","key":"1244_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1182\/blood.V43.4.485.485","volume":"43","author":"J Bonhomme","year":"1974","unstructured":"Bonhomme J, Seligmann M, Mihaesco C, Clauvel JP, Danon F, Brouet JC, et al. MU-chain disease in an African patient. Blood. 1974;43(4):485\u201392.","journal-title":"Blood"},{"issue":"6","key":"1244_CR13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1001\/archinte.1979.03630430048015","volume":"139","author":"J-C Brouet","year":"1979","unstructured":"Brouet J-C, Seligmann M, Danon F, Belpomme D, Fine J-M. \u00b5-Chain Disease: Report of Two New Cases. Arch Intern Med. 1979;139(6):672\u20134.","journal-title":"Arch Intern Med"},{"issue":"6","key":"1244_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0145-2126(93)90129-9","volume":"17","author":"M Cogn\u00e9","year":"1993","unstructured":"Cogn\u00e9 M, Aucouturier P, Brizard A, Dreyfus B, Duarte F, Preud\u2019homme J-L. Complete variable region deletion in A\u03b1 heavy chain disease protein (roul). Correlation with light chain secretion. Leuk Res. 1993;17(6):527\u201332.","journal-title":"Leuk Res"},{"issue":"5","key":"1244_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1182\/blood.V43.5.713.713","volume":"43","author":"F Dammacco","year":"1974","unstructured":"Dammacco F, Bonomo L, Franklin EC. A new case of mu heavy chain disease: clinical and immunochemical studies. Blood. 1974;43(5):713\u20139.","journal-title":"Blood"},{"issue":"1","key":"1244_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-0609.1975.tb01048.x","volume":"15","author":"F Danon","year":"1975","unstructured":"Danon F, Mihaesco C, Bouvry M, Clerc M, Seligmann M. A new case of heavy mu-chain disease. Scand J Haematol. 1975;15(1):5\u20139.","journal-title":"Scand J Haematol"},{"issue":"3","key":"1244_CR17","first-page":"622","volume":"45","author":"H Fujii","year":"1982","unstructured":"Fujii H, Shimizu T, Seki S, Isemura T, Yamamoto K, Kanoh T, et al. Combined features of mu-heavy chain disease and primary macroglobulinemia in a single patient: clinical and immunological studies. Nihon Ketsueki Gakkai Zasshi. 1982;45(3):622\u201332.","journal-title":"Nihon Ketsueki Gakkai Zasshi"},{"issue":"49","key":"1244_CR18","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1055\/s-0028-1107673","volume":"97","author":"HJ Germann","year":"1972","unstructured":"Germann HJ, Westerhausen M, Kickh\u00f6fen B. \u03bc-Kettenkrankheit*. Dtsch Med Wochenschr. 1972;97(49):1902\u20135.","journal-title":"Dtsch Med Wochenschr"},{"issue":"3","key":"1244_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1600-0609.1976.tb01140.x","volume":"16","author":"V J\u00f8nsson","year":"1976","unstructured":"J\u00f8nsson V, Videb\u00e6k A, Axelsen NH, Harboe M. \u03bc-Chain Disease in a Case of Chronic Lymphocytic Leukaemia and Malignant Histiocytoma. Scandinavian Journal of Haematology. 1976;16(3):209\u201317.","journal-title":"Scandinavian Journal of Haematology"},{"issue":"1","key":"1244_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0002-9343(73)90091-0","volume":"54","author":"AS Josephson","year":"1973","unstructured":"Josephson AS, Nicastri A, Price E, Biro L. H chain fragment and monoclonal IgA in a lymphoproliferative disorder. Am J Med. 1973;54(1):127\u201335.","journal-title":"Am J Med"},{"issue":"2","key":"1244_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/10245330410001671561","volume":"9","author":"K Kinoshita","year":"2004","unstructured":"Kinoshita K, Yamagata T, Nozaki Y, Sugiyama M, Ikoma S, Funauchi M, et al. \u03bc-Heavy Chain Disease Associated with Systemic Amyloidosis. Hematology. 2004;9(2):135\u20137.","journal-title":"Hematology"},{"issue":"6","key":"1244_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/rheumatology\/26.6.460","volume":"26","author":"IH Leach","year":"1987","unstructured":"Leach IH, Jenkins JS, Murray-Leslie CF, Powell RJ. Mu-heavy chain and monoclonal IgG K paraproteinaemia in systemic lupus erythematosus. Br J Rheumatol. 1987;26(6):460\u20132.","journal-title":"Br J Rheumatol"},{"issue":"3","key":"1244_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.7326\/0003-4819-75-3-407","volume":"75","author":"SL Lee","year":"1971","unstructured":"Lee SL, Rosner F, Ruberman W, Glasberg S. Mu-chain disease. Ann Intern Med. 1971;75(3):407\u201314.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1244_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/clinchem\/27.2.331","volume":"27","author":"DS O'Reilly","year":"1981","unstructured":"O\u2019Reilly DS, Adjukiewicz A, Whicher JT. Biochemical findings in a case of mu-chain disease. Clin Chem. 1981;27(2):331\u20133.","journal-title":"Clin Chem"},{"issue":"2","key":"1244_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/0002-9343(78)90828-8","volume":"65","author":"W Pruzanski","year":"1978","unstructured":"Pruzanski W, Hasselback R, Katz A, Parr DM. Multiple myeloma (light chain disease) with rheumatoid-like amyloid arthropathy and mu-heavy chain fragment in the serum. Am J Med. 1978;65(2):334\u201341.","journal-title":"Am J Med"},{"issue":"1","key":"1244_CR26","first-page":"89","volume":"28","author":"M Silva-Moreno","year":"1983","unstructured":"Silva-Moreno M, Ruiz-Arguelles GJ, Lopez-Karpovitch X, Labardini-Mendez J. Heavy chain disease. Report of four cases. Sangre (Barc). 1983;28(1):89\u201398.","journal-title":"Sangre (Barc)"},{"issue":"9","key":"1244_CR27","first-page":"847","volume":"51","author":"A Tamura","year":"2003","unstructured":"Tamura A, Yamashiro A, Mizutani F, Oita T, Maeda A, Takahashi T. Immunochemical properties of free mu-chain protein in a patient with mu-heavy chain disease. Rinsho Byori. 2003;51(9):847\u201351.","journal-title":"Rinsho Byori"},{"issue":"2","key":"1244_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/BF00422499","volume":"94","author":"O Wetter","year":"1979","unstructured":"Wetter O, Schmidt CG, Linder KH, Leene W. H-Kettenkrankheit: Humorale und cellul\u00e4re Befunde bei sechs F\u00e4llen vom \u03bc-Kettentyp. J Cancer Res Clin Oncol. 1979;94(2):207\u201323.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"1244_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s002770050448","volume":"77","author":"M Witzens","year":"1998","unstructured":"Witzens M, Egerer G, Stahl D, Werle E, Goldschmidt H, Haas R. A case of \u03bc heavy-chain disease associated with hyperglobulinemia, anemia, and a positive Coombs test. Ann Hematol. 1998;77(5):231\u20134.","journal-title":"Ann Hematol"},{"issue":"2","key":"1244_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1182\/blood.V59.2.207.207","volume":"59","author":"RW Schroff","year":"1982","unstructured":"Schroff RW, Foon KA, Billing RJ, Fahey JL. Immunologic Classification of Lymphocytic Leukemias Based on Monoclonal Antibody-Defined Cell Surface Antigens. Blood. 1982;59(2):207\u201315.","journal-title":"Blood"},{"issue":"4","key":"1244_CR31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3816\/CLM.2005.n.008","volume":"5","author":"ZR Hunter","year":"2005","unstructured":"Hunter ZR, Branagan AR, Manning R, Patterson CJ, Ditzel Santos D, Tournilhac O, et al. CD5, CD10, and CD23 Expression in Waldenstr\u00f6m\u2019s Macroglobulinemia. Clin Lymphoma. 2005;5(4):246\u20139.","journal-title":"Clin Lymphoma"}],"updated-by":[{"DOI":"10.1186\/s13000-022-01265-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000}}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01244-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-022-01244-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01244-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T06:19:16Z","timestamp":1666333156000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-022-01244-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1244"],"URL":"https:\/\/doi.org\/10.1186\/s13000-022-01244-1","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,5]]},"assertion":[{"value":"3 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13000-022-01265-w","URL":"https:\/\/doi.org\/10.1186\/s13000-022-01265-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"David L Murray has intellectual property rights to the MASS-FIX assay and patents. The other authors have no conflicts related to this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}